Surrogate Outcomes: An Inevitable Limitation of Hyperbilirubinemia-Driven Randomized Controlled Trials
- PMID: 33260178
- DOI: 10.1159/000512021
Surrogate Outcomes: An Inevitable Limitation of Hyperbilirubinemia-Driven Randomized Controlled Trials
Comment on
-
The Choice of Population and Outcomes in Neonatal Trials on Hyperbilirubinemia: Are They Relevant? An Analysis of Cochrane Neonatal Reviews.Neonatology. 2020;117(6):687-693. doi: 10.1159/000511656. Epub 2020 Dec 2. Neonatology. 2020. PMID: 33264799
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
